首页> 外文期刊>Cancer biology & therapy >A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
【24h】

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach

机译:胃的侵袭性标志性戒指细胞癌的患者中CDH1基因的新突变

获取原文
获取原文并翻译 | 示例
       

摘要

Germline mutations in CDH1, the gene coding for the E-cadherin adhesion protein, are known to cause hereditary diffuse gastric cancer. We identified a new truncating germline mutation (p.Asp538Thrfs*19) in exon 11 of the CDH1 gene in a 41-year-old male with a diffuse gastric cancer. Although he had no parental history of gastric cancer, the co-segregation study in the family detected the same mutation in his healthy 31-year-old brother. The mutation affects one of the extracellular repeat (CAD repeats) domains which is essential for the homophilic binding specificity that directs "E-cadherin" to bind with itself each others. In this case, immunohistochemical analysis showed no expression of E-cadherin in the tumor sample and was a useful prescreening tool to genetic testing. This finding was associated with a poor response to trastuzumab-based treatment.
机译:CDH1中的种系突变,已知对e-cadherin粘附蛋白的基因进行编码,以引起遗传弥漫性胃癌。 我们在41岁的男性中,在CDH1基因的外显子11中鉴定了一种新的截断种系突变(P.asp538Thrfs * 19),其中41岁的男性,其中41岁的雄性患有弥漫性胃癌。 虽然他没有胃癌的父母史,但家庭的共同分离研究发现了他健康的31岁的兄弟中的相同突变。 该突变影响了一种细胞外重复(CAD重复)结构域,这对于使“e-cadherin”引导“E-cadherin”与其它彼此结合的同性恋结合特异性至关重要。 在这种情况下,免疫组织化学分析显示在肿瘤样品中没有表达E-Cadherin,并且是遗传测试的有用的预筛选工具。 该发现与对基于曲妥珠单抗的治疗的反应不佳。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号